| Product Code: ETC7646489 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Bipolar Disorder Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Bipolar Disorder Therapeutics Market - Industry Life Cycle |
3.4 Israel Bipolar Disorder Therapeutics Market - Porter's Five Forces |
3.5 Israel Bipolar Disorder Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Bipolar Disorder Therapeutics Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
4 Israel Bipolar Disorder Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health conditions in Israel |
4.2.2 Growing acceptance of pharmacological treatments for bipolar disorder |
4.2.3 Rising demand for innovative therapies and personalized medicine in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders in the society |
4.3.2 Limited access to specialized healthcare professionals for bipolar disorder treatment in some regions of Israel |
4.3.3 Stringent regulatory requirements for approval of new therapeutics in the market |
5 Israel Bipolar Disorder Therapeutics Market Trends |
6 Israel Bipolar Disorder Therapeutics Market, By Types |
6.1 Israel Bipolar Disorder Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Mood Stabilizers, 2021- 2031F |
6.1.4 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Antipsychotic Drugs, 2021- 2031F |
6.1.5 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Antidepressant Drugs, 2021- 2031F |
6.1.6 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Israel Bipolar Disorder Therapeutics Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.3 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Serotonin-norepinephrine Reuptake Inhibitors, 2021- 2031F |
6.2.4 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Tricyclic Antidepressants, 2021- 2031F |
6.2.5 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Monoamine Oxidase Inhibitors, 2021- 2031F |
6.2.6 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.2.7 Israel Bipolar Disorder Therapeutics Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
7 Israel Bipolar Disorder Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Bipolar Disorder Therapeutics Market Export to Major Countries |
7.2 Israel Bipolar Disorder Therapeutics Market Imports from Major Countries |
8 Israel Bipolar Disorder Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for bipolar disorder therapies in Israel |
8.2 Adoption rate of new treatment modalities by healthcare providers |
8.3 Patient adherence and compliance rates to prescribed therapeutic regimens |
8.4 Rate of relapse and hospital readmission among bipolar disorder patients |
9 Israel Bipolar Disorder Therapeutics Market - Opportunity Assessment |
9.1 Israel Bipolar Disorder Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Bipolar Disorder Therapeutics Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10 Israel Bipolar Disorder Therapeutics Market - Competitive Landscape |
10.1 Israel Bipolar Disorder Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Bipolar Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here